Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Dan Zhao

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5152894406. Sources: ClinicalTrials.gov.

Their work

Papers
1 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2023: 1 trial · 2024: none · 2025: none · 2026: 1 paper

Papers 1

  1. Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1093/oncolo/oyag423↗

Trials 1

  1. Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients Principal investigator NCT05634525↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael James Overman · 1 shared paper, 2026 · strength 0.19
  2. Matthew H. G. Katz · 1 shared paper, 2026 · strength 0.19
  3. Abdelrahman M.G. Yousef · 1 shared paper, 2026 · strength 0.19
  4. Jason A. Willis · 1 shared paper, 2026 · strength 0.19
  5. Saikat Chowdhury · 1 shared paper, 2026 · strength 0.19
  6. Ahmed Elhariri · 1 shared paper, 2026 · strength 0.19
  7. Robert A. Wolff · 1 shared paper, 2026 · strength 0.19
  8. Naruhiko Ikoma · 1 shared paper, 2026 · strength 0.19
  9. Mahmoud Yousef · 1 shared paper, 2026 · strength 0.19
  10. Haoqiang Ying · 1 shared paper, 2026 · strength 0.19
  11. Rebecca Anne Snyder · 1 shared paper, 2026 · strength 0.19
  12. Ethan Bernard Ludmir · 1 shared paper, 2026 · strength 0.19
  13. Anirban Maitra · 1 shared paper, 2026 · strength 0.19
  14. Eugene Jon Koay · 1 shared paper, 2026 · strength 0.19
  15. Brandon George Smaglo · 1 shared paper, 2026 · strength 0.19
  16. Huamin Wang · 1 shared paper, 2026 · strength 0.19
  17. Shubham Pant · 1 shared paper, 2026 · strength 0.19
  18. Ryan W. Huey · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.